Welcome

【停牌】無【複牌】688053ST思科瑞(維權)603517ST絕味(維權)600624ST複華(維權)3

利和興:擬通過定增募資開展的半導體設備精密零部件研發及產業化項目處於前期籌備階段。後

Read More

Experience

奧布替尼(宜諾凱®)為一款處於後期臨床階段、具有潛在同類最佳優勢的高中樞神經係統滲透性、選擇性、不可逆口服小分子BTK抑製劑。白銀

Read More

Resources

經申請,公司股票及可轉換公司債券自2025年9月22日起停牌,預計停牌時間不超過2個交易日。中金黃金:中國黃金集團內蒙古礦業有限公

Read More

Cases

【增減持】宏華數科:股東新湖智腦擬減持不超2.5%公司股份宏華數科公告,持股8.75%的浙江新湖智腦投資管理合夥企業(有限合夥)(

Read More

News & Events

[10-08-2015]

There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour.

[10-08-2015]

There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour.